Medicare’s Insulin Demo Project Likely Depends On Plan Interest

Manufacturers are on board for ‘Part D Senior Savings Model’ that would set a $35 copay cap, but added risk corridor payments may be the key to getting PBMs to offer the enhanced plans focused on reducing insulin costs for patients.

Diabetes

More from Pricing Debate

More from Market Access